U.S. Leisure Stock News

Why This New Collaboration Matters For Charles River Laboratories International Stock Charles River Laboratories International (CRL) has drawn fresh attention after announcing a collaboration with Arovella Therapeutics to provide GMP Next Generation Sequencing services for ALA-101, a CAR-iNKT cell therapy targeting certain blood cancers. The agreement aligns with ongoing concerns about Charles River Laboratories International's core business performance, where recent summaries point to...

Enova International (ENVA) has just posted Q2 2026 results with revenue of US$470.2 million and basic EPS of US$4.22, set against trailing 12 month revenue of about US$1.7 billion and EPS of US$14.30 that reflect a 38.7% earnings increase over the past year. Over the last six reported quarters, revenue has moved from US$345.6 million in Q1 2025 to US$470.2 million in Q2 2026, while quarterly basic EPS has shifted from US$2.84 to US$4.22. This gives investors a clearer view of how top line and...

Alcoa Corporation recently reported second-quarter 2026 results, with sales rising to US$3,966 million and net income to US$407 million, alongside higher earnings per share versus a year earlier. At the same time, Alcoa trimmed its 2026 alumina production and shipment guidance due to refinery disruptions, even as aluminum output projections remained unchanged and options activity pointed to heightened market expectations for volatility. Now we’ll examine how Alcoa’s strong quarterly earnings...

Warner Bros. Discovery (WBD) is back in focus after the European Commission cleared its proposed acquisition by Paramount Skydance Corporation. This clearance is a key regulatory milestone that comes alongside ongoing antitrust challenges in the United States. See our latest analysis for Warner Bros. Discovery. At a share price of $25.77, Warner Bros. Discovery has seen short term share price pressure, with its 1 month share price return down 5.26%, even as the 1 year total shareholder return...

Mobileye Global (MBLY) has reported Q2 2026 revenue of US$508 million with a basic EPS loss of US$0.03 and net income loss of US$21 million, putting fresh numbers in front of a market already focused on the company’s path to profitability. Over recent quarters the company has seen revenue move between US$438 million and US$558 million, while basic EPS has ranged from a small loss of US$0.03 to a much larger quarterly loss of US$4.67, highlighting how volatile reported earnings have been...

Nordic American Tankers reported that the tanker market remains exceptionally strong, while three vessels previously trapped in the Arabian Gulf since February 28, 2026 have been released and returned to global trading, and a separate Black Sea attack caused only minor damage with the crew unharmed. This combination of a very strong operating backdrop and the restoration of previously disrupted capacity materially improves the company’s near‑term operational flexibility and earnings...

Paychex stock has retreated over the past year, yet the current US$113.55 share price sits at a point where the Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside, while traditional earnings multiples look roughly in line with the market. That split leaves investors weighing a seemingly attractive DCF signal against a more neutral read from broader valuation checks. Over the last 12 months, Paychex has delivered a decline of 20.7%, which puts recent returns at...

Earlier this week, CSX Corporation reported second-quarter 2026 results showing revenue of US$3,935 million and net income of US$1,002 million, alongside confirmed full‑year 2026 guidance for mid‑ to high‑single‑digit revenue growth and operating margin expansion of more than 350 basis points. The company paired these results with an ongoing capital return program, repurchasing over 127.72 million shares under its 2023 authorization and affirming a US$0.14 quarterly dividend, highlighting...

Rising tensions in the Red Sea have put critical shipping lanes and energy infrastructure in the spotlight, and that is feeding directly into how investors think about large infrastructure and engineering stocks. When oil routes and key facilities face higher security risks, the companies that build, maintain or secure essential assets can see sentiment shift quickly, for better or worse. This article looks at three stocks from our Global Infrastructure & Engineering Companies screener that...

In recent weeks, reports indicate Manchester United have reached an agreement in principle on personal terms with Roma midfielder Manu Kone, as the club intensifies its search for a third midfield signing following departures and injuries. This potential £51m acquisition highlights Manchester United’s commitment to reshaping its midfield core amid strong competition from European and Saudi clubs, reinforcing the club’s effort to build a deeper squad for upcoming campaigns. We’ll now...

At its 2026 Annual Meeting of Shareholders held on September 10, 2026, ePlus Inc. secured board approval for a proposal to amend its Certificate of Incorporation to lift authorized common shares from 50,000,000 to 75,000,000, keeping preferred shares unchanged at 2,000,000 and raising total authorized capital stock to 77,000,000, subject to shareholder approval. This planned increase in authorized common stock gives ePlus added flexibility to fund future business and financial initiatives,...

Insight Enterprises (NSIT) has drawn fresh attention after a recent move in its share price, with the stock last closing at $117.65. Investors are weighing this level against the company’s fundamentals and recent return profile. See our latest analysis for Insight Enterprises. The recent 1-day share price return of 1.72% and 90-day share price return of 60.66% place Insight Enterprises firmly in a momentum phase, although the 1-year total shareholder return declined 19.32%, showing a...

Ionis Pharmaceuticals (IONS) is under renewed scrutiny after reporting that its late stage CARDIO TTRansform trial for eplontersen with AstraZeneca did not meet the primary efficacy endpoint, triggering a sharp share price reaction and a shareholder investigation. See our latest analysis for Ionis Pharmaceuticals. The eplontersen trial failure and shareholder investigation come after a sharp shift in momentum for Ionis Pharmaceuticals, with the share price down 26.10% over 30 days and 29.02%...

Bath & Body Works (BBWI) stock is drawing renewed attention after the company announced its entry into Brazil, opening its first store and digital channel in a market known for strong fragrance and self-care demand. See our latest analysis for Bath & Body Works. At a share price of $19.90, Bath & Body Works has seen its 30-day share price return fall 8.76%, and its 1-year total shareholder return decline 34.43%. This suggests recent momentum has been weak even as investors react to the Brazil...

Investors in CSX Corporation ( NASDAQ:CSX ) had a good week, as its shares rose 4.9% to close at US$53.23 following the...

Kinder Morgan, Inc. ( NYSE:KMI ) just released its quarterly report and things are looking bullish. The company beat...

CareTrust REIT has delivered a strong share price run over the past three years, yet the current checks paint a mixed valuation picture that leaves investors weighing a solid return record against only a partial signal that the stock is still cheap on fundamentals. The stock has returned 137.7% over three years, which puts recent gains at the center of any discussion about whether new buyers are paying up for that performance. Future rent growth and cash flows from its healthcare-focused...

Freedom Holding (FRHC) drew fresh investor attention after signing Memoranda of Understanding with Antom, a payment services provider under Ant International, to build cross border payment solutions for Kazakhstani users shopping on Chinese e commerce platforms. See our latest analysis for Freedom Holding. At a share price of $151.02, Freedom Holding has pulled back slightly over the last week but still shows a 30 day share price return of 11.49% and a year to date share price return of...

SS&C Technologies Holdings (SSNC) has reported a clean set of Q2 2026 numbers, with revenue of US$1.7 billion and basic EPS of US$0.99, alongside trailing 12 month EPS of US$3.58. Over the past few quarters the company has seen revenue move from US$1.54 billion in Q2 2025 to US$1.70 billion in Q2 2026, while basic EPS has risen from US$0.74 to US$0.99. This puts the focus on how a 13.2% trailing net margin shapes the quality of these results for investors. See our full analysis for SS&C...

Alignment Healthcare stock has delivered a very strong 237.9% return over the past three years, yet its valuation checks still suggest the shares screen as cheap rather than stretched. That contrast is now running head on into fresh legal and regulatory questions that could affect how investors think about the quality and sustainability of the company’s earnings. A 237.9% three year gain positions Alignment Healthcare as a major winner over that period, so any hint that its growth story is...

Ball (BALL) is drawing fresh attention after recent share price moves, with the stock closing at $63.84 compared with a widely discussed fair value marker of $70.79 that points to a possible valuation gap. See our latest analysis for Ball. Recent moves in Ball's share price, including the 1 day share price return of 2.59% and year to date share price return of 19.66%, come alongside a fair value narrative of $70.79 and a discounted cash flow estimate that points to a potential valuation gap...

With the Federal Reserve sending mixed signals on future rate cuts and hikes, inflation estimates edging higher, and oil prices reacting to conflict in Iran, many investors are taking a fresh look at large cap defensive dividend stocks. These companies, often in Consumer Staples, Utilities, and Healthcare, are commonly viewed as potential anchors when monetary policy and inflation expectations feel uncertain. This article focuses on how that backdrop connects to our US Large Cap Defensive...

Avnet stock has delivered a strong 145.2% return over the past 5 years, yet the company scores poorly on broader valuation checks, leaving investors weighing a solid track record against signals that the shares may not be a simple bargain at the current US$89.42 price. Over 5 years, Avnet has returned 145.2%, which puts recent gains into context as investors assess how much of the story is already reflected in the share price. Avnet's ability to convert its electronics distribution business...

Recent coverage of InvenTrust Properties (IVT) is centering on its pattern of annual dividend increases, a moderate payout ratio, and analyst expectations for earnings growth, all of which are drawing fresh attention from income-focused investors. See our latest analysis for InvenTrust Properties. At a share price of $36.45, InvenTrust Properties has posted a 12.12% 90 day share price return and a 30.74% year to date share price return. The 1 year total shareholder return of 36.62% and 3 year...